Clinical Trial: Safety and Tolerability Study for the Pneumococcal Conjugate Vaccine V114 Versus Prevnar™ (V114-001 EXT1)(COMPLETED)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Multicenter, Double-Blind Study of the Safety, Tolerability, and Immunogenicity of Pneumococcal Conjugate Vaccine (V114) Compared to Prevnar™ in Healthy Adults and Toddlers

Brief Summary: This study is being conducted to evaluate the safety, tolerability, and immunogenicity of 15-valent Pneumococcal conjugate vaccine (V114) compared to Prevnar™ in healthy adults and toddlers.